Integrated Wealth Concepts LLC Mannkind Corp Transaction History

Integrated Wealth Concepts LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$2.62 - $4.45 $4,016 - $6,821	-1,533 Reduced 10.43%	13,172 $48,000
Q4 2021 Feb 15, 2022	BUY	$4.05 - $5.37 $10,125 - $13,425	2,500 Added 20.48%	14,705 $64,000
Q3 2021 Nov 15, 2021	BUY	$3.89 - $5.48 $85 - $120	22 Added 0.18%	12,205 $53,000
Q2 2021 Aug 13, 2021	BUY	$3.61 - $5.45 $43,980 - $66,397	12,183 New	12,183 $66,000
Q4 2020 Feb 12, 2021	SELL	$1.79 - $4.04 $21,394 - $48,286	-11,952 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$1.56 - $2.08 $18,645 - $24,860	11,952 New	11,952 $22,000
Q1 2020 May 18, 2020	SELL	$0.84 - $1.76 $28,589 - $59,901	-34,035 Closed	0 $0
Q4 2019 Feb 20, 2020	BUY	$1.14 - $1.49 $21,633 - $28,275	18,977 Added 126.03%	34,035 $44,000
Q2 2019 Aug 15, 2019	BUY	$1.09 - $1.88 $16,413 - $28,309	15,058 New	15,058 $68,000

244

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.57B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Integrated Wealth Concepts LLC, based on Form 13F filings with the SEC.

Stay updated on Integrated Wealth Concepts LLC with notifications on news.